World Health Organisation

WHO shelves redefinintion amidst protest from Indian drug makers

27 Jan 2009

WHO has decided to drop a move to redefine "counterfeit" medicine, that pharma multinationals had lobbied for, following strong opposition from generics manufacturers in India, Brazil and other developing countries

WHO grants international non-proprietary name Melogliptin to Glenmark Pharmaceuticals's anti-diabetic drug

14 Jan 2008

Kill the killer

By By 2020 one in eight dea | 01 May 2003

View details about the software product Informachine News Trackers